Lv1
34 积分 2024-02-28 加入
Lentiviral In Vivo CD19 CAR T-Cell Therapy in Neurologic Autoimmune Disorders
4天前
已完结
Validation of a mutated PRE sequence allowing high and sustained transgene expression while abrogating WHV-X protein synthesis: application to the gene therapy of WAS
1个月前
已完结
Toward In Vivo CAR T Cell Therapy: Perfecting CAR and Lipid Nanoparticle Design
3个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
4个月前
已完结
Detect-seq, a chemical labeling and biotin pull-down approach for the unbiased and genome-wide off-target evaluation of programmable cytosine base editors
5个月前
已完结
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia
5个月前
已完结
High-fidelity AaCas12bMax enables the development of an engineered T cell therapy with enhanced safety and functional fitness
5个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
6个月前
已完结
Preparation and characterization of a chimeric CD19 monoclonal antibody
9个月前
已完结
Watershed year of cell and gene therapy (CGT): A review of 2024 CGT approvals
9个月前
已完结
皖公网安备34019202002308
